Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.
Current Team (3)Update
Funding Rounds (2) - $20MUpdate
Board Members and Advisors (3)Update
Bessemer Venture Partners has over 100 years of investing experience, with a portfolio ranging...
Third Rock Ventures invests in transformational life science companies that show high growth...
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and...
One Newton Executive Park
Newton, MA 02462